Introduction
============

Stroke is the second most common cause of death worldwide,[@b1-por-8-107] and its risk is increased five times with atrial fibrillation (AF).[@b2-por-8-107] While catheter ablation reduces the burden of AF compared with drug therapy,[@b3-por-8-107],[@b4-por-8-107] it is not known whether this results in reduced stroke risk.[@b5-por-8-107] Large randomized trials on this subject -- Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial and Early Treatment of Atrial Fibrillation for Stroke Prevention Trial -- will not report for several years. Several retrospective cohort design studies have addressed the same question but are limited by potential confounding due to unmeasured risks.[@b6-por-8-107]--[@b10-por-8-107]

We sought to overcome this key limitation by examining trends over time within the same populations. Using routinely collected data, we examined rates of ischemic stroke or transient ischemic attack (stroke/TIA) in patients undergoing ablation and two matched control cohorts with AF, one having undergone direct current cardioversion. Comparing stroke/TIA rates across cohorts and over time, we hypothesized that there would be a difference in temporal trends after the intervention date.

Methods
=======

Data source
-----------

The data source for this study was an anonymized dataset of predefined variables created from the Hospital Episode Statistics (HES) data warehouse, including records from 1996 to 2013. HES contains details of all hospital admissions, outpatient appointments, and accident and emergency attendances at National Health Service hospitals in England. HES records include clinical diagnoses and procedures; patient demographics; and administrative information from inpatient visits since 1989, outpatient visits since 2003, and accident and emergency visits since 2007. The records used for this study included all patients with a diagnosis of AF International Classification of Diseases, tenth edition (ICD-10 code I48) recorded at any time prior to the end of 2013.

Patient selection
-----------------

Patients included in the analysis population for this study were required to have at least one AF diagnosis (ICD-10 code I48) during or after 2008 to ensure capture of contemporary treatments. Patients with a record of AF prior to April 2005 were excluded to eliminate patients known to have very long-standing AF. In addition, patients were excluded for diagnoses or procedures denoting evidence of valvular heart disease, atrioventricular node ablation, pacemaker, implantable cardioverter defibrillator, or any operation on the heart conduction system at or prior to the cohort-specific index date ([Table S1](#SD1-por-8-107){ref-type="supplementary-material"}).

Cohort selection
----------------

From the selected patients, a pulmonary vein ablation (PVA) treatment cohort was defined as those patients who had an AF ablation incorporating percutaneous transluminal pulmonary vein isolation (ICD-10 procedure code K621) as their primary procedure, simultaneously with a primary AF diagnosis. Exclusions for this cohort included any additional catheter or surgical ablation of the heart prior to the index PVA ([Table S1](#SD1-por-8-107){ref-type="supplementary-material"}). A general AF control cohort was defined as those patients with at least two hospital records and no catheter or surgical ablation of the heart at any time. Additionally, a cardioversion control cohort was defined as the subset of the general AF control cohort with a record of direct current cardioversion (ICD-10 procedure code X501 or X502) simultaneously with a primary AF diagnosis.

Baseline definitions and data conventions
-----------------------------------------

The index date (time zero) was defined as the date of the first PVA, the first cardioversion, and the second hospital record of any type in the dataset, for the PVA, cardioversion, and general AF cohorts, respectively.

Baseline risk factors were defined via diagnosis and procedure codes observed within 3 years prior to a patient's index date ([Table S1](#SD1-por-8-107){ref-type="supplementary-material"}). Risk factors included diagnoses of previous stroke or TIA, hypertension, diabetes mellitus, heart failure, peripheral vascular disease, coronary artery disease, sleep apnea, hemorrhagic stroke, cardiomyopathy, obesity, other arrhythmias or conduction disorders, chronic kidney disease, COPD, hyperlipidemia, and pulmonary disease, as well as procedures for coronary artery bypass graft and percutaneous coronary intervention. CHADS~2~ and CHA~2~DS~2~-VASc scores[@b11-por-8-107],[@b12-por-8-107] for stroke risk were also calculated.

Cohort matching
---------------

In order to reduce selection bias and create cohorts of patients that were clinically well matched with respect to available risk information, a combination of propensity and direct matching was used to match ablation patients in a 1:1 ratio with patients in the general AF control cohort, and separately to patients in the cardioversion cohort.

Propensity scores, defined as the patients' probabilities of having PVA treatment based on their individual characteristics at or prior to their index date, were calculated separately for each control cohort from logistic regression models. Potential predictors in the propensity models included all baseline risk factors, as previously defined, with stepwise selection used to retain only those conditions that significantly impacted treatment cohort. The resulting propensity scores summarize patients' probabilities of being in the ablation cohort vs each control cohort given their unique baseline comorbidity profile.

The two sets of propensity score, one for each control group, were used simultaneously with additional metrics to match ablation patients with general AF controls and separately with cardioversion controls. A SAS macro called gmatch, developed by the Mayo Clinic Biomedical Statistics and Informatics Division, was used to match patients in a 1:1 ratio on age, sex, year of index date, time from AF diagnosis to index date, and the resulting comorbidity-based propensity scores.[@b13-por-8-107]

Stroke endpoints
----------------

The primary outcomes of interest were occurrence of ischemic stroke/TIA (ICD-10 diagnosis codes I63-I64x, G45) within 1-year intervals over equal time spans before and after a patient's index date. The pre- and postindex analysis interval for each patient was equal to their follow-up from index date to last visit. Hospital and specialty care records were assumed to be comprehensive for all patients within this interval.

Binary stroke/TIA endpoints were created for each patient, for each year of their analysis interval, to indicate the occurrence of ischemic stroke or TIA events within the year. Patients with a stroke/TIA in a postindex year for which they did not have complete follow-up were included for that year to avoid bias from stroke mortality. Counts of patients with stroke/TIA and event rates for each year of follow-up were summarized by analysis cohort.

Statistical modeling
--------------------

Generalized estimating equations with binary distributions and log link functions were utilized to model stroke/TIA event rates by year for each set of matched cohorts. Repeated measures methodology with unstructured correlation was used to account for the lack of statistical independence among multiple endpoints for each patient.

Separate models were utilized to test for the impact of PVA treatment on stroke risk in the preindex period and the postindex period due to the expectation that treatment would change the pattern or slope of stroke/TIA rates over time. Two preindex models, one for each pair of matched analysis cohorts, were constructed to test the assumption that baseline stroke risks were similar in the risk-matched cohorts. They included cohort and year as predictors, with year as a categorical variable, and cohort--year interaction included only if significant at a level of α =0.05. Two similar postindex models were constructed to test whether the stroke risk patterns over time were similar or different after divergence in AF treatment pathways.

All statistical analyses in this study were performed using SAS software, Version 9.2 (SAS Institute, Inc., Cary, NC, USA). All data used to perform this analysis were deidentified and accessed in compliance with the Health Insurance Portability and Accountability Act. As a retrospective analysis of a deidentified database, the research was exempt from Independent Review Board review under 45 Code of Federal Regulations 46.101(b)(4).

Results
=======

A total of 1,409,106 patients had a diagnosis of AF, of which 6,356 met all inclusion and exclusion criteria for the PVA cohort. An additional 81,189 patients met the criteria for the cardioversion cohort, and 1,312,339 patients met the criteria for the general AF cohort. These cohorts formed the eligible populations from which matched pairs of PVA and cardioversion patients, and separately matched pairs of PVA and general AF patients, were chosen.

Matched populations
-------------------

Of the 6,356 patients in the PVA cohort, 4,991 patients were matched to an equal number of general AF controls, and 5,407 patients were separately matched to cardioversion controls. CHADS~2~ and CHA~2~DS~2~-VASc risk score profiles were nearly identical between the two cohorts in each match (*p*-values 0.5588 and 0.6948, respectively, for PVA vs general AF; *p*-values 0.7428 and 0.8152 for PVA vs cardioversion). Age and sex distributions were also similar between cohorts, with the majority of patients 45--75 years of age and approximately 70% male. Since an AF diagnosis was required in 2008 or later and the data were only complete through 2013, most patients had index dates between 2008 and 2013, with nearly half of them in 2012 or 2013 ([Table 1](#t1-por-8-107){ref-type="table"}).

The time from first AF diagnosis to index date was similar in the matched PVA vs general AF controls, as this requirement was added to the matching algorithm to ensure that controls were not matched prior to their first AF diagnosis (means: 15 months). The matched PVA vs cardioversion controls were less similar since this timing was not a matching requirement, resulting in the PVA cohort having AF of longer duration than the cardioversion control cohort (means: 21 months PVA, 5 months cardioversion; [Table 1](#t1-por-8-107){ref-type="table"})

The average length of available follow-up after index through the end of the 2013 was over 2 years for all cohorts, with median durations close to 2 years ([Table 1](#t1-por-8-107){ref-type="table"}). The number of patients with sufficient follow-up through their last visit record to be included in each year of the statistical models is shown by cohort and year in [Table 2](#t2-por-8-107){ref-type="table"}. In addition, this table shows the number of patients who dropped out of the analysis population for each year due to having a record of death in a hospital setting or due to reaching the end of 2013. Deaths in a hospital setting after index were consistently higher in the control cohorts than in the PVA cohorts.

Endpoint summary
----------------

In the PVA vs general AF matched cohorts, unadjusted stroke/TIA rates were similar between the cohorts in the year immediately prior to their index date, and both cohorts had increased stroke/TIA rates in the index year compared with prior years ([Figure 1A](#f1-por-8-107){ref-type="fig"}). The increase in stroke rates during the index year was due in part to strokes occurring on the index date, which was a visit to the hospital system (including outpatient specialist visits). The stroke rates on this single day were 0.74% in the general AF cohort and 0.26% in the PVA cohort, leaving 1.02% and 0.39% stroke rates, respectively, occurring in the remainder of the first year. After the index date, the general AF cohort had consistently higher stroke/TIA rates than the PVA cohort, rising steadily through 4 years postindex, while the rate in the PVA cohort steadily decreased until the rate was nearly nine times as high in the general AF control cohort. Stroke/TIA rates were then similar in the fifth year, at which time the combined population had decreased to just 469 patients.

The PVA vs cardioversion control matched cohorts showed a pattern similar to the first match, although somewhat less regular ([Figure 1B](#f1-por-8-107){ref-type="fig"}). Some notable differences were the higher stroke/TIA rates in this PVA cohort 1--4 years prior to the index date, and the higher stroke/TIA rates in the cardioversion control cohort for the year immediately prior to the index date. The index date accounted for 0.13% of the strokes in the cardioversion control cohort and 0.36% in the PVA cohort within the first year after treatment, leaving 0.66% and 0.51% rates, respectively, for the remainder of the first year. Since the cardioversion controls had a shorter duration of preceding AF, their higher stroke/TIA rate in the year before index suggests that a number of these events may have triggered the initial AF diagnosis.

Of the patients with stroke occurring on their index date, only a single PVA patient had another stroke in a subsequent year. This patient was represented in both matched populations and had a record of a second stroke in the second analysis year. No control patients in either the matched cardioversion cohort or the matched general AF cohort had strokes at index and also in a subsequent year. In addition, no patients with stroke occurring on their index date died in a hospital setting at any time through 2013.

Statistical modeling results
----------------------------

In both matched populations, statistical models of patient risk for stroke/TIA in the preindex time frame show similar event rates between cohorts (*p*=0.8292 for PVA vs general AF and 0.5198 for PVA vs cardioversion; [Table 3](#t3-por-8-107){ref-type="table"}). The similar preindex event rates indicate that cohort matching was successful in creating cohorts with similar baseline stroke risks.

Postindex model results are also consistent between the two matched populations, but these models show a significantly lower risk of stroke/TIA events in PVA patients vs matched control groups over 5 years postindex (*p*\<0.0001 for PVA vs general AF and 0.0222 for PVA vs cardioversion). Adjusted mean rates in PVA patients were 60% of the rates in matched cardioversion controls and 35% of the rates in general AF matches (0.82% PVA vs 1.37% cardioversion, *p*=0.0222; 0.64% PVA vs 1.84% general AF; *p*\<0.0001). The large difference in postindex event rates and similar preindex rates suggests a divergence in outcomes stemming from the difference in treatment pathways beginning at the index date.

Discussion
==========

In this very large population, matching resulted in almost identical CHA~2~DS~2~-VASc scores and stroke/TIA rates between cohorts prior to the index date. After the index date -- on which ablation or cardioversion occurred -- the adjusted rate of stroke/TIA was significantly lower in ablation patients than in either the cardioversion or the general AF control cohorts (40% and 65% lower, respectively). Repeated measures methodology, which observes the same patients before and after intervention, has not previously been utilized to determine whether catheter ablation of AF reduces stroke risk. The similarity in stroke risk between cohorts prior to the index date suggests that confounding by unmeasured variables is not responsible for subsequent differences, while the divergence following the index date suggests a treatment effect beginning on that date.

No studies have prospectively tested whether the superiority of catheter ablation over antiarrhythmic drugs in restoring sinus rhythm[@b3-por-8-107],[@b4-por-8-107] results in a lower risk of stroke/TIA. Investigators have reported stroke/TIA rates \<1%/year among patients with CHA~2~DS~2~-VASc scores ≥2 and discontinued anticoagulation following AF ablation.[@b14-por-8-107]--[@b17-por-8-107] Registry data have also shown that patients who maintain sinus rhythm following ablation have stroke/TIA rates similar to age- and sex-matched patients with no AF history.[@b18-por-8-107] Large randomized trials -- Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial and Early Treatment of Atrial Fibrillation for Stroke Prevention Trial -- are not expected to be completed until 2018--2019. Two retrospective cohort studies, each with 4,212 PVA patients, used age and sex matching,[@b6-por-8-107] and CHADS~2~ score matching,[@b7-por-8-107] to show that stroke/TIA risk in the PVA patients was similar to patients without AF, and significantly lower than in patients with AF but without intervention. Two subsequent papers used propensity matching to compare populations of over 800 matched PVA and AF control pairs each, resulting in PVA groups with significantly lower stroke/TIA rates.[@b8-por-8-107],[@b9-por-8-107] Propensity matching was also used to show a significantly lower stroke/TIA rate in 12,122 PVA patients compared with AF patients who had undergone cardioversion.[@b10-por-8-107]

While matching technologies can greatly reduce bias, they are still limited by the possibility of confounding due to unmeasured variables. The key strength of this study is the unique combination of tight matching and repeated measures methodology used to overcome this limitation. The tight matching of patient stroke risks ensures that stroke rates are similar among cohorts at baseline, while repeated measures methodology examines the effect of intervention over time in the same patients. Together, these provide confidence that the drop in stroke rates for the PVA cohorts after index is a consequence of treatment.

Until large randomized trials report, clinicians will need to judge from these data whether catheter ablation of AF reduces the risk of stroke. Previous cohort studies have been consistent in showing a large benefit toward PVA. The current study examines the modern era of PVA with \>80% of procedures performed during or after 2010. Its results are consistent with previous studies, but greatly reduce the likelihood of selection bias by demonstrating equal stroke risks between cohorts prior to PVA.

These results, coupled with prior results suggesting that ablation prevents progression of paroxysmal to persistent AF[@b19-por-8-107] and its consequent morbidity and mortality,[@b20-por-8-107],[@b21-por-8-107] raise important questions for clinicians. Current guidelines recommend catheter ablation be performed only in symptomatic patients.[@b22-por-8-107],[@b23-por-8-107] Additionally, they recommend that anticoagulation be continued late after ablation in patients with elevated CHA~2~DS~2~-VASc scores.[@b24-por-8-107] These recommendations are potentially impacted by the results of this study.

Limitations
===========

The primary limitation of this study is its reliance on routinely collected data, which may lack the sensitivity and specificity of prospectively collected data. Stroke/TIA rates may be underestimated, but this would be expected to affect all cohorts proportionately. The study could not differentiate types of AF, and thus the benefit of PVA may not be consistent across all stages of AF. Anticoagulation usage was unknown and could vary between groups, although the tight matching on CHADS~2~ and CHA~2~DS~2~-VASc scores minimizes this risk, as does comparison to a cardioversion cohort. In previous studies where anticoagulation data were available, usage was similar between cohorts.[@b8-por-8-107],[@b9-por-8-107] Recent adoption of continued oral anticoagulation at ablation could reduce the postindex stroke rate even further,[@b25-por-8-107] as might newer techniques that improve long-term maintenance of sinus rhythm.[@b26-por-8-107] It is important to note that despite the careful cohort matching combined with methodology that used patients as their own controls over time, residual confounding is still a possibility due to data limitations.

Conclusion
==========

Propensity matching of AF patients with PVA treatment to similar patients with cardioversion or with neither treatment resulted in cohorts with the same baseline rate of stroke/TIA. Following treatment, the stroke/TIA rate was significantly lower in the PVA cohort than in either control cohort.

Supplementary material
======================

###### 

Diagnosis or procedure codes

  Diagnosis or procedure                                                                                                              Definition
  ----------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------
  Ablation -- atrial flutter                                                                                                          Any of the following OPCS-4 codes appear in any procedure field:
  K622 -- Percutaneous transluminal ablation of atrial wall for atrial flutter                                                        
  K623 -- Percutaneous transluminal ablation of conducting system of heart for atrial flutter NEC (April 2007 onward)                 
  Ablation -- atrioventricular node                                                                                                   Any of the following OPCS-4 codes appear in any procedure field:
  K521 -- Open ablation of atrioventricular node                                                                                      
  K571 -- Percutaneous transluminal ablation of atrioventricular node                                                                 
  Ablation -- other foci                                                                                                              Any of the following OPCS-4 codes appear in any procedure field:
  K574 -- Percutaneous transluminal ablation of accessory pathway (April 2006 onward)                                                 
  K575 -- Percutaneous transluminal ablation of atrial wall NEC (April 2006 onward)                                                   
  K578 -- Other specified other therapeutic transluminal operations on heart                                                          
  Ablation -- pulmonary vein                                                                                                          Any of the following OPCS-4 codes appear in any procedure field:
  K621 -- Percutaneous transluminal ablation of pulmonary vein to left atrium conducting system (April 2007 onward)                   
  Atrial fibrillation or flutter                                                                                                      Any of the following ICD-10 codes appear in any diagnosis field:
  I48X -- Atrial fibrillation or flutter                                                                                              
  Cardiomyopathy                                                                                                                      Any of the following ICD-10 codes appear in any diagnosis field:
  I42 -- Cardiomyopathy                                                                                                               
  I43 -- Cardiomyopathy in diseases classified elsewhere                                                                              
  I255 -- Ischemic cardiomyopathy                                                                                                     
  Cardiomyopathy -- hypertrophic                                                                                                      Any of the following ICD-10 codes appear in any diagnosis field:
  I421 -- Obstructive hypertrophic cardiomyopathy                                                                                     
  I422 -- Other hypertrophic cardiomyopathy                                                                                           
  Cardioversion                                                                                                                       Any of the following OPCS-4 codes appear in any procedure field:
  X501 -- Direct current cardioversion                                                                                                
  X502 -- External cardioversion NEC                                                                                                  
  Chronic kidney disease                                                                                                              Any of the following ICD-10 codes appear in any diagnosis field:
  I12 -- Hypertensive renal disease                                                                                                   
  I13 -- Hypertensive heart and renal disease                                                                                         
  N18 -- Chronic kidney disease                                                                                                       
  COPD                                                                                                                                Any of the following ICD-10 codes appear in any diagnosis field:
  J439 -- Emphysema, unspecified                                                                                                      
  J44 -- Other chronic obstructive pulmonary disease                                                                                  
  Coronary artery bypass graft                                                                                                        Any of the following OPCS-4 codes appear in any procedure field:
  K40 -- Saphenous vein graft replacement of coronary artery                                                                          
  K41 -- Other autograft replacement of coronary artery                                                                               
  K42 -- Allograft replacement of coronary artery                                                                                     
  K43 -- Prosthetic replacement of coronary artery                                                                                    
  K44 -- Other replacement of coronary artery                                                                                         
  K45 -- Connection of thoracic artery to coronary artery                                                                             
  K46 -- Other bypass of coronary artery                                                                                              
  Coronary artery disease                                                                                                             Any of the following ICD-10 codes appear in any diagnosis field:
  I20 -- Angina pectoris                                                                                                              
  I21 -- Acute myocardial infarction                                                                                                  
  I22 -- Subsequent myocardial infarction                                                                                             
  I23 -- Certain current complications following acute myocardial infarction                                                          
  I24 -- Other acute ischemic heart diseases                                                                                          
  I25 -- Chronic ischemic heart disease                                                                                               
  Z951 -- Presence of aortocoronary bypass graft                                                                                      
  Diabetes mellitus                                                                                                                   Any of the following ICD-10 codes appear in any diagnosis field:
  E10 -- Insulin-dependent diabetes mellitus                                                                                          
  E11 -- Noninsulin-dependent diabetes mellitus                                                                                       
  E12 -- Malnutrition-related diabetes mellitus                                                                                       
  E13 -- Other specified diabetes mellitus                                                                                            
  E14 -- Unspecified diabetes mellitus                                                                                                
  Heart failure                                                                                                                       Any of the following ICD-10 codes appear in any diagnosis field:
  I110 -- Hypertensive heart disease with (congestive) heart failure                                                                  
  I130 -- Hypertensive heart and renal disease with (congestive) heart failure                                                        
  I132 -- Hypertensive heart and renal disease with both (congestive) heart failure and renal failure                                 
  I50 -- Heart failure                                                                                                                
  Hyperlipidemia                                                                                                                      Any of the following ICD-10 codes appear in any diagnosis field:
  E780 -- Pure hypercholesterolemia                                                                                                   
  E781 -- Pure hyperglyceridemia                                                                                                      
  E782 -- Mixed hyperlipidemia                                                                                                        
  E783 -- Hyperchylomicronemia                                                                                                        
  E784 -- Other hyperlipidemia                                                                                                        
  E785 -- Hyperlipidemia, unspecified                                                                                                 
  Hypertension                                                                                                                        Any of the following ICD-10 codes appear in any diagnosis field:
  I10 -- Essential (primary) hypertension                                                                                             
  I11 -- Hypertensive heart disease                                                                                                   
  I12 -- Hypertensive renal disease                                                                                                   
  I13 -- Hypertensive heart and renal disease                                                                                         
  I15 -- Secondary hypertension                                                                                                       
  Obesity                                                                                                                             Any of the following ICD-10 codes appear in any diagnosis field:
  E66 -- Obesity                                                                                                                      
  Other arrhythmias/conduction disorders                                                                                              Any of the following ICD-10 codes appear in any diagnosis field:
  I44 -- Atrioventricular and left bundle-branch block                                                                                
  I45 -- Other conduction disorders                                                                                                   
  I47 -- Paroxysmal tachycardia                                                                                                       
  I49 -- Other cardiac arrhythmias                                                                                                    
  Other operations on the heart conduction system                                                                                     Any of the following OPCS-4 codes appear in any procedure field:
  K522 -- Epicardial excision of rhythmogenic focus                                                                                   
  K523 -- Endocardial excision of rhythmogenic focus                                                                                  
  K524 -- Open division of accessory pathway within heart                                                                             
  K525 -- Open division of conducting system of heart NEC                                                                             
  K528 -- Other specified open operations on conducting system of heart                                                               
  K529 -- Unspecified open operations on conducting system of heart                                                                   
  K572 -- Percutaneous transluminal ablation of conducting system of heart NEC                                                        
  K573 -- Percutaneous transluminal removal of foreign body from heart (April 2006 onward)                                            
  Pacemaker or implantable cardioverter defibrillator (ICD)                                                                           Any of the following OPCS-4 codes appear in any procedure field:
  K591 -- Implantation of cardioverter defibrillator using one electrode lead                                                         
  K592 -- Implantation of cardioverter defibrillator using two electrode leads                                                        
  K593 -- Resiting of lead of cardioverter defibrillator                                                                              
  K594 -- Renewal of cardioverter defibrillator                                                                                       
  K595 -- Removal of cardioverter defibrillator                                                                                       
  K596 -- Implantation of cardioverter defibrillator using three electrode leads                                                      
  K598 -- Other specified cardioverter defibrillator introduced through the vein                                                      
  K599 -- Unspecified cardioverter defibrillator introduced through the vein                                                          
  K601 -- Implantation of intravenous cardiac pacemaker system NEC                                                                    
  K602 -- Resiting of lead of intravenous cardiac pacemaker system                                                                    
  K603 -- Renewal of intravenous cardiac pacemaker system                                                                             
  K604 -- Removal of intravenous cardiac pacemaker system                                                                             
  K605 -- Implantation of intravenous single chamber cardiac pacemaker system                                                         
  K606 -- Implantation of intravenous dual chamber cardiac pacemaker system                                                           
  K607 -- Implantation of intravenous biventricular cardiac pacemaker system                                                          
  K608 -- Other specified cardiac pacemaker system introduced through vein                                                            
  K609 -- Unspecified cardiac pacemaker system introduced through vein                                                                
  K611 -- Implantation of cardiac pacemaker system NEC                                                                                
  K612 -- Resiting of lead of cardiac pacemaker system NEC                                                                            
  K613 -- Renewal of cardiac pacemaker system NEC                                                                                     
  K614 -- Removal of cardiac pacemaker system NEC                                                                                     
  K615 -- Implantation of single chamber cardiac pacemaker system                                                                     
  K616 -- Implantation of dual chamber cardiac pacemaker system                                                                       
  K617 -- Implantation of biventricular cardiac pacemaker system                                                                      
  K618 -- Other specified other cardiac pacemaker system                                                                              
  K619 -- Unspecified other cardiac pacemaker system                                                                                  
  U311 -- Distant pacemaker test                                                                                                      
  U318 -- Other specified pacemaker testing                                                                                           
  U319 -- Unspecified pacemaker testing                                                                                               
  OR                                                                                                                                  
  Any of the following ICD-10 codes appear in any diagnosis field:                                                                    
  Z450 -- Adjustment and management of cardiac pacemaker                                                                              
  Z950 -- Presence of cardiac pacemaker                                                                                               
  Percutaneous coronary intervention                                                                                                  Any of the following OPCS-4 codes appear in any procedure field:
  K49 -- Transluminal balloon angioplasty of coronary artery                                                                          
  K50 -- Other therapeutic transluminal operations on coronary artery                                                                 
  K75 -- Percutaneous transluminal balloon angioplasty and insertion of stent into coronary artery (only available from April 2006)   
  Peripheral vascular disease (PVD)                                                                                                   Any of the following ICD-10 codes appear in any diagnosis field:
  I70 -- Atherosclerosis                                                                                                              
  I71 -- Aortic aneurysm and dissection                                                                                               
  I72 -- Other aneurysm and dissection                                                                                                
  I73 -- Other peripheral vascular diseases                                                                                           
  I74 -- Arterial embolism and thrombosis                                                                                             
  I798 -- Other disorders of arteries, arterioles, and capillaries in diseases classified elsewhere                                   
  Pulmonary disease                                                                                                                   Any of the following ICD-10 codes appear in any diagnosis field:
  I26 -- Pulmonary embolism                                                                                                           
  I27 -- Other pulmonary heart diseases                                                                                               
  I28 -- Other diseases of pulmonary vessels                                                                                          
  Sleep apnea                                                                                                                         Any of the following ICD-10 codes appear in any diagnosis field:
  G473 -- Sleep apnea                                                                                                                 
  Stroke -- hemorrhagic                                                                                                               Any of the following ICD-10 codes appear in any diagnosis field:
  I60 -- Subarachnoid hemorrhage                                                                                                      
  I61 -- Intracerebral hemorrhage                                                                                                     
  I62 -- Other nontraumatic intracranial hemorrhage                                                                                   
  Stroke -- ischemic                                                                                                                  Any of the following ICD-10 codes appear in any diagnosis field:
  I63 -- Cerebral infarction                                                                                                          
  I64X -- Stroke, not specified as hemorrhage or infarction                                                                           
  Transient ischemic attack                                                                                                           Any of the following ICD-10 codes appear in any diagnosis field:
  G45 -- Transient cerebral ischemic attacks and related syndromes                                                                    
  Valvular disease                                                                                                                    Any of the following OPCS-4 codes appear in any procedure field:
  K253 -- Prosthetic replacement of mitral valve                                                                                      
  K263 -- Prosthetic replacement of aortic valve                                                                                      
  OR                                                                                                                                  
  Any of the following ICD-10 codes appear in any diagnosis field:                                                                    
  I05 -- Rheumatic mitral valve diseases                                                                                              
  I06 -- Rheumatic aortic valve diseases                                                                                              
  I07 -- Rheumatic tricuspid valve diseases                                                                                           
  I08 -- Multiple valve diseases                                                                                                      
  I091 -- Rheumatic diseases of endocardium, valve unspecified                                                                        
  I34 -- Nonrheumatic mitral valve disorders                                                                                          
  I35 -- Nonrheumatic aortic valve disorders                                                                                          
  I36 -- Nonrheumatic tricuspid valve disorders                                                                                       
  I37 -- Pulmonary valve disorders                                                                                                    
  I38 -- Endocarditis, valve unspecified                                                                                              
  I39 -- Endocarditis and heart valve disorders in diseases classified elsewhere                                                      
  Z952 -- Presence of prosthetic heart valve                                                                                          
  Z953 -- Presence of xenogenic heart valve                                                                                           
  Vascular disease                                                                                                                    Any of the components in these fields:
  Coronary artery disease                                                                                                             
  Peripheral vascular disease                                                                                                         
  Coronary artery bypass graft                                                                                                        
  Percutaneous coronary intervention                                                                                                  

**Abbreviations:** NEC, not elsewhere classified; ICD, International Classification of Diseases; OPCS, Office of Population Censuses and Surveys.
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![Yearly observed stroke rates in matched cohorts. (**A**) PVA vs matched general AF cohorts; (**B**) PVA vs matched cardioversion cohorts.\
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###### 

Baseline patient characteristics

  Characteristics                                                                 PVA vs AF match (N=4,991 per cohort)   PVA vs CV match (N=5,407 per cohort)            
  ------------------------------------------------------------------------------- -------------------------------------- -------------------------------------- -------- --------
  CHADS~2~ risk score[a](#tfn1-por-8-107){ref-type="table-fn"}                                                                                                           
   0                                                                              62.8%                                  63.0%                                  58.7%    58.9%
   1                                                                              29.2%                                  29.1%                                  32.6%    32.7%
   2                                                                              6.9%                                   7.0%                                   7.4%     7.1%
   3                                                                              1.0%                                   0.8%                                   1.1%     1.1%
   4                                                                              0.1%                                   0.2%                                   0.1%     0.1%
   ≥5                                                                             0.0%                                   0.0%                                   0.0%     0.0%
  CHA~2~DS~2~-VASc risk score[a](#tfn1-por-8-107){ref-type="table-fn"}                                                                                                   
   0                                                                              34.6%                                  33.8%                                  33.5%    33.5%
   1                                                                              30.9%                                  31.7%                                  30.6%    30.8%
   2                                                                              19.4%                                  19.9%                                  19.8%    20.0%
   3                                                                              10.3%                                  10.1%                                  11.1%    10.9%
   4                                                                              3.4%                                   3.4%                                   3.6%     3.8%
   5                                                                              1.2%                                   0.9%                                   1.2%     0.9%
   6                                                                              0.2%                                   0.1%                                   0.2%     0.1%
   ≥7                                                                             0.0%                                   0.0%                                   0.0%     0.0%
  Age group at index date                                                                                                                                                
   \<35                                                                           3.0%                                   3.2%                                   2.6%     2.6%
   35 to \<45                                                                     9.1%                                   8.8%                                   8.1%     8.1%
   45 to \<55                                                                     22.6%                                  22.5%                                  21.5%    21.4%
   55 to \<65                                                                     35.9%                                  36.2%                                  37.3%    37.4%
   65 to \<75                                                                     25.4%                                  24.9%                                  26.4%    26.4%
   75 to \<85                                                                     4.0%                                   4.2%                                   4.0%     4.0%
   85+                                                                            0.1%                                   0.2%                                   0.1%     0.1%
  Sex                                                                                                                                                                    
   Female                                                                         30.9%                                  30.9%                                  29.6%    29.6%
   Male                                                                           69.1%                                  68.9%                                  70.4%    70.4%
   Undetermined                                                                   0.0%                                   0.2%                                   0.0%     0.0%
  Year of index date                                                                                                                                                     
   2007                                                                           2.0%                                   2.3%                                   2.0%     1.9%
   2008                                                                           6.8%                                   6.5%                                   6.4%     6.7%
   2009                                                                           10.2%                                  10.5%                                  9.7%     9.4%
   2010                                                                           12.7%                                  13.9%                                  12.8%    12.8%
   2011                                                                           17.8%                                  17.7%                                  17.5%    17.4%
   2012                                                                           23.4%                                  23.2%                                  23.3%    23.4%
   2013                                                                           24.9%                                  24.3%                                  26.3%    26.3%
   2014                                                                           2.3%                                   1.6%                                   2.1%     2.1%
  Months from first AF to index date[b](#tfn2-por-8-107){ref-type="table-fn"}                                                                                            
   Mean                                                                           15                                     15                                     21       5
   Median                                                                         9                                      9                                      13       0
   Interquartile range                                                            0--22                                  0--22                                  0--33    0--5
  Months of follow-up after index date[c](#tfn3-por-8-107){ref-type="table-fn"}                                                                                          
   Mean                                                                           28.1                                   28.9                                   27.5     27.8
   Median                                                                         24.0                                   25.0                                   24.0     23.0
   Interquartile range                                                            11--42                                 12--44                                 11--41   11--42

**Notes:**

Based on diagnoses and procedures recorded within 3 years prior to the index date;

first AF is based on a diagnosis seen in a hospital setting;

follow-up is measured through the end of 2013.

**Abbreviations:** AF, atrial fibrillation; CV, cardioversion; PVA, pulmonary vein ablation.

###### 

Sample sizes and reasons for loss to follow-up by year

  PVA vs General AF match                                                                                                                                                                                                  
  ------------------------- ------------------------------------------------------------------------------- -------------------------------------- ------------------------------------- ---------------- ---------------- -------
  ±1 year                   2,444                                                                           3,083                                  60                                    7                1,289            1,355
  ±2 years                  1,572                                                                           1,819                                  28                                    7                512              868
  ±3 years                  963                                                                             1,072                                  29                                    5                384              521
  ±4 years                  527                                                                             572                                    9                                     1                235              320
  ±5 years                  227                                                                             242                                    9                                     0                213              240
                                                                                                                                                                                                                           
  **PVA vs CV match**                                                                                                                                                                                                      
                                                                                                                                                                                                                           
  **Follow-up**             **Population size with utilization[a](#tfn5-por-8-107){ref-type="table-fn"}**   **Died in hospital during the year**   **Data ended prior to end of year**                                     
  **CV control**            **PVA cohort**                                                                  **CV control**                         **PVA cohort**                        **CV control**   **PVA cohort**   
                                                                                                                                                                                                                           
  ±1 year                   3,049                                                                           3,319                                  16                                    10               1,533            1,534
  ±2 years                  1,876                                                                           1,944                                  17                                    7                832              949
  ±3 years                  1,137                                                                           1,147                                  9                                     4                521              562
  ±4 years                  599                                                                             598                                    11                                    1                342              359
  ±5 years                  275                                                                             254                                    3                                     0                228              250

**Notes:**

Follow-up is measured through the last date of hospital utilization only.

**Abbreviations:** AF, atrial fibrillation; CV, cardioversion; PVA, pulmonary vein ablation.

###### 

Repeated measures logistic regression model results[a](#tfn7-por-8-107){ref-type="table-fn"}

  Model estimates of stroke rates   Adjusted overall mean   Standard error of mean   *p*-value for cohort comparison
  --------------------------------- ----------------------- ------------------------ ---------------------------------
  PVA vs general AF match                                                            
   Preindex model                                                                    
    PVA cohort                      0.30%                   0.08%                    0.8292
    Control cohort                  0.28%                   0.07%                    
   Postindex model                                                                   
    PVA cohort                      0.64%                   0.11%                    \<0.0001
    Control cohort                  1.84%                   0.23%                    
  PVA vs cardioversion match                                                         
   Preindex model                                                                    
    PVA cohort                      0.37%                   0.09%                    0.5198
    Control cohort                  0.42%                   0.08%                    
   Postindex model                                                                   
    PVA cohort                      0.82%                   0.15%                    0.0222
    Control cohort                  1.37%                   0.18%                    

**Notes:**

Models included cohort and year as predictors, with year as a categorical variable and cohort--year interaction included only when statistically significant.

**Abbreviations:** AF, atrial fibrillation; PVA, pulmonary vein ablation.
